Real-time enrollment status for this phelan-mcdermid syndrome clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 9:34 PM UTC
| NCT Number | NCT07281079 |
| Recruiting Status | Recruiting |
| Condition | Phelan-McDermid Syndrome |
| Phase | PHASE3 |
| Target Enrollment | 160 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Neuren Pharmaceuticals Limited |
| Last Updated on CT.gov | August 25, 2026 (3 days ago) |
As of August 28, 2026: Clinical trial NCT07281079 is currently recruiting participants. This phase3 study for phelan-mcdermid syndrome is actively seeking new participants at 14 locations across the United States. The study is sponsored by Neuren Pharmaceuticals Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07281079 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07281079 was last updated 3 days ago (August 25, 2026). HelloStudys verifies this status automatically.